We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
mRNA疫苗Moderna对抗流感在4万名参与者的试验中优于传统疫苗。了解这将如何改变市场以及FDA决定何时出台。
